Ratings by Wolfe Research
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 10/15/2026 | Rudy Li | Ovid Therapeutics Inc | OVID | New Coverage | Outperform (N/A) |
5.00 (N/A) |
2.19 (2.15) |
-1.83% | Details |
| 10/15/2026 | Rudy Li | Bright Minds Biosciences Inc. | DRUG | New Coverage | Outperform (N/A) |
150.00 (N/A) |
50.71 (51.30) |
1.16% | Details |
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 6,049 more... | |||||||||



